Innovate UK, GB and other funders: Canada-UK: Biomanufacturing of Biologics and Advanced Therapies

17/08/2023

17/10/2023

The aim of this competition is to stimulate the development and implementation of innovative technologies in biomanufacturing. The objective is to build the desired flexibility and technical capabilities required for the development and economically sustainable production of the next generation vaccines and therapies. Award amount max CAD 1,000,000.

Your joint Canadian and UK project must focus on innovative technologies that enable the development and manufacturing of novel biological therapeutic products and delivery system, which can include: vaccines (prophylactic, therapeutic, various platforms) therapeutic proteins advanced therapy medicinal products, including messenger RNA, small interfering RNA, gene therapies, cell therapies, engineered tissues other biological based therapies, such as bacteriophage or engineered probiotics viral and non-viral, for example Lipid Nano Particles (LNP) platforms, including their components and payloads, as delivery systems for protein and nucleic acids.

Country of applicant institution Canada; United Kingdom Nationality of researcher Unrestricted Applicant type Academic Institution; Commercial or Private Sector; Government or Public Sector; Non-profit. Projects should have a balanced contribution of the total eligible project costs among the partners from the participating partner countries. No one country or project partner can represent more than 70% of the total project cost.